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Review
The U.S. Environmental Protection Agency 
(EPA) funded five academic centers in 
1999 to address the uncertainties in expo-
sure, toxicity and health effects of airborne 
particulate matter (PM) identified in the 
“Research Priorities for Airborne Particulate 
Matter” of the National Research Council 
(NRC 1998). Centers were established 
at Harvard University (Boston, MA), New 
York University (New York, NY), University 
of Rochester (Rochester, NY), University 
of Washington (Seattle, WA), University 
of California (Irvine, CA), University of 
California (Los Angeles, CA), and University 
of Southern California (Los Angeles, CA). All 
centers were structured to promote interdis-
ciplinary approaches to address the research 
priorities of the NRC. A midterm report of 
PM Center findings was published previously 
(Lippmann et al. 2003). This report high-
lights selected accomplishments from the first 
6 years of the PM Centers, with a focus on the 
advantages of interdisciplinary, center-based 
research. A more detailed summary of research 
findings and bibliography may be found in 
supplemental material available from the U.S. 
EPA PM Centers website (U.S. EPA 2008).
PM Exposure Research 
Highlights
Characterization of ambient PM. The PM 
Centers worked to characterize ambient PM 
and the substantial variation of concentration 
and composition with source, region, sea-
sonal and diurnal patterns, and size fraction. 
Examples of these findings follow. In the 
eastern United States, PM2.5 (PM with aero-
dynamic diameter < 2.5 µm) composition 
varies seasonally, with relatively more sul-
fate from long-range transport in the winter, 
and nitrate in the summer. Substantial spatial 
variability in PM components and copoll-
utants was observed (Maciejczyk and Chen 
2005). In the Pacific Northwest, organic 
carbon (OC) derived from wood burning 
is a major contributor to fine particle mass 
(Larson et al. 2006). PM10 (PM < 10 µm in 
aerodynamic diameter) collected in Southern 
California derives largely from road dust and 
soil and contains significant quantities of 
metals, whereas PM2.5 from the same loca-
tions contains primarily nitrates, OC, and 
elemental carbon (EC). Ultrafine PM (UFP; 
PM < 0.1 µm in aerodynamic diameter) is 
especially high in OC (Sardar et al. 2005). 
Semivolatile components of PM have received 
increased attention in recent investigations, 
especially with regard to combustion-derived 
UFP in which a significant fraction of emis-
sions by mass can consist of semivolatile mate-
rial that has condensed onto a non  volatile, 
primarily carbon core (Kuhn et al. 2005a; 
Robinson et al. 2007). Atmospheric processes 
generate UFP in regions of the Los Angeles, 
California, air basin that receive advected pol-
lutant air masses (Fine et al. 2004; Singh et al. 
2006). The role of atmospheric chemistry 
in formation of UFP is important: photo-
oxidation of diesel emissions rapidly generates 
organic PM (Ntziachristos et al. 2007). 
Source apportionment. Research on 
sources emphasized mobile sources/traffic 
during the first 6 years of the PM Centers 
(see below). A workshop was held by the PM 
Centers to compare different methods for 
source apportionment of PM. The outcomes 
of different analytical methods found good 
agreement across different investigators and 
methods in apportioning sources of PM2.5 
mass in two U.S. cities: Phoenix, Arizona, 
and Washington, D.C. (Hopke et al. 2006; 
Thurston et al. 2005). Center research also 
included identification of tracer compounds 
for use in identifying sources of ambient par-
ticles (Fine et al. 2004).
Personal exposure. A significant body of 
data on personal exposure resulted from field 
studies of the PM Centers, including longitu-
dinal studies conducted in different airsheds, 
populations, and housing. Extensive intra- 
personal and interpersonal variability in the 
ratio of personal to ambient exposure meas-
ures was observed in some studies (Liu et al. 
2003), but taken collectively the data establish 
that ambient air concentrations at central site 
monitors can yield valid estimates of average 
personal exposure for population-based epi-
demiologic studies (Sarnat et al. 2000, 2002). 
The location of central site monitors, extent 
of PM penetration into indoor environments, 
personal activities, and the influence of 
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indoor PM sources can affect personal/ambi-
ent exposure ratios (Larson et al. 2004; Sarnat 
et al. 2006). The effects of these factors differ 
with PM size and composition; for example, 
freeway-derived UFP in the 70- to 100-nm 
range penetrated indoors to a greater extent 
than 10- to 20-nm PM (Zhu et al. 2005). 
The relationship of ambient criteria pollut-
ant concentrations to ambient and personal 
PM2.5 was explored. Ambient criteria pollut-
ant levels were better predictors of personal 
PM2.5 than they were of personal exposure 
to the gaseous species themselves, suggesting 
that the criteria pollutants may be useful as 
surrogates of PM2.5 exposure, but are unlikely 
to act as confounders in epidemiologic stud-
ies (Sarnat et al. 2005). In a study of ambient 
UFP, hourly and 24-hr number concentra-
tions were not significantly associated with 
concentrations of gaseous copollutants (Sardar 
et al. 2004).
PM Health Effects and 
Mechanisms of Injury Highlights
During the effort of the U.S. EPA to establish 
a national ambient air quality standard for 
fine particles, considerable questions about 
the biological plausibility of epidemiologic 
findings on hospitalization and mortality from 
cardiopulmonary effects arose. As a result 
the NRC committee recommended research 
into the mechanisms of injury that under-
lie PM health effects, especially daily mor-
tality. Developments in defining toxicologic 
mechanisms and intermediate clinical condi-
tions that may explain the observed cardiovas-
cular mortality are one of the highest impact 
areas of the scientific contributions of the PM 
Centers, in particular by addressing PM size-
specific research, for example, ultrafine, fine, 
and coarse PM.
PM effects on the cardiovascular system. 
The PM Centers convened a workshop to dis-
cuss potential mechanisms of PM-associated 
cardiovascular effects and to identify fruitful 
research approaches [Frampton et al. 2009 (in 
press; Utell et al. 2002] (Figure 1). During the 
first 6 years, center investigators have contrib-
uted to several review papers on cardiovascular 
responses to inhaled UFP and PM2.5 (Brook 
et al. 2004; Delfino et al. 2005; Godleski 
2006; Mar et al. 2006; Pope and Dockery 
2006). New statistical methodology was devel-
oped and applied to strengthen the interpreta-
tion of acute mortality studies (Coull et al. 
2001; Janes et al. 2005; Schwartz and Coull 
2003; Zanobetti et al. 2000, 2001; Zeka and 
Schwartz 2004). Epidemiologic studies that 
focused on specific cardiovascular outcomes, 
such as myocardial infarction (Peters et al. 
2001, 2004; Zanobetti and Schwartz 2005) or 
cause-specific mortality (Franklin et al. 2007; 
Miller et al. 2007; Pope et al. 2002; Zeka 
et al. 2005) produced hypotheses for test-
ing in laboratory animal research and human 
clinical studies. Toxicologists have contrib-
uted by identifying cellular and biomolecular 
mechanisms involved in the cardiovascular 
effects that result from acute and long-term 
exposures to ambient PM (Araujo et al. 2008; 
Corey et al. 2006; Lippmann et al. 2005a, 
2006; Sun et al. 2005). Most recently, toxico-
logic studies (Ghelfi et al. 2008) have shown 
that increases in reactive oxygen species 
(ROS) in the heart associated with inhalation 
of concentrated ambient particles (CAPs) may 
be abrogated by blocking neural receptors in 
the lung (Figure 2).
Investigations in the PM Centers and else-
where supported the hypothesis that inflam-
matory responses contribute to cardiovascular 
toxicity. Possible mechanisms were proposed. 
Pulmonary inflammation could release 
ROS, cytokines, and chemokines from the 
lung to the systemic circulation (Frampton 
et al. 2006b). Vascular inflammatory mark-
ers were associated with PM2.5 exposure in 
a subchronic mouse study (Sun et al. 2005). 
Gong et al. (2007), which demonstrated that 
both diesel extract and oxidized lipid com-
ponents synergistically affect the expression 
profile of several gene modules related to vas-
cular inflammatory processes. Evidence for an 
increase in C-reactive protein and a shift to 
a procoagulatory state of the blood was seen 
in coronary artery disease patients exposed 
to various size fractions of PM (Rückerl et al. 
2006). Temporal and other parameters dif-
fered with the specific air pollution mixture in 
this study, which limited interpretation. Pope 
et al. (2004) concluded that fine particulate 
air pollution is a risk for cause-specific cardio-
vascular disease mortality via inflammation, 
accelerated atherosclerosis, and altered auto-
nomic function. Zeka et al. (2006) reached 
similar conclusions. Their epidemiologic study 
supports the hypothesis that particles can 
induce cardiovascular disease through inflam-
matory pathways and suggests greater toxicity 
of traffic-related particles.
Autonomic function effects manifested as 
alterations in heart rate and heart rate vari-
ability (HRV) have been associated with PM2.5 
exposure. Decreased HRV was associated with 
Figure 1. Mechanistic pathways for PM cardiovascular effects. Abbreviations: ET, endothelin; MI, myocar-
dial infarction; NO, nitric oxide; TF, tissue factor. Modified from Frampton et al. 2009 (in press) with permis-
sion from Wolters Kluwer. 
Inhaled
PM
Vascular
endothelial
injury
Airway
epithelial
injury
Autonomic
nervous
system
HRV,
altered
repolarization
Cardiac
arrhythmia
Sudden
death
NO
Platelet activation
TF expression,
reduced fibrinolysis
Thrombosis
Vasoconstriction,
endothelial
dysfunction
Atherosclerosis
Acute MI Congestive
heart failure
Pulmonary
hypertension,
systemic hypertension
ET
Figure 2. Capsazepine (CPZ) aerosolization pre-
vents oxidative stress and damage in the heart of 
rats exposed to CAPs. Adult Sprague-Dawley rats 
received aerosols containing either 500 µM CPZ 
or saline for 20 min immediately prior to exposure 
to CAPs. Values represent the mean of eight inde-
pendent determinations ± SEM. Reproduced from 
Ghelfi et al. (2008) with permission from Society of 
Toxicology. 
*p < 0.05.
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PM2.5 exposure in panel studies of elderly 
subjects (Adar et al. 2007; Henneberger et al. 
2005; Schwartz et al. 2005a). No associations 
with altered heart rate or HRV were seen in 
Seattle during the winter woodburning sea-
son (Mar et al. 2005b; Sullivan et al. 2005). A 
population-based study that drew on an estab-
lished cohort (the Normative Aging Study) 
confirmed the association between decreased 
HRV and PM2.5 seen in other studies; history 
of ischemic heart disease, hypertension, and 
diabetes modified the effects of PM2.5 (Park 
et al. 2005). Cardiac arrhythmias and vascular 
changes such as endothelial cell responses and 
alterations in blood pressure are other impor-
tant clinical signs of cardiovascular toxicity that 
have been identified in both humans and ani-
mals exposed to PM (Frampton et al. 2006b; 
Gong et al. 2004; Nadziejko et al. 2002). 
Atherosclerosis is emerging as an impor-
tant toxic end point of PM2.5 exposure. 
Atherosclerosis findings may be related to 
reports of myocardial infarction associated with 
PM2.5 in epidemiologic studies (Peters et al. 
2004; Zanobetti and Schwartz 2005). The 
Peters study relates traffic exposures and myo-
cardial infarction. Atherosclerotic lesions in a 
susceptible mouse model were enhanced by 
PM2.5 exposure in a number of reports (Araujo 
et al. 2008; Chen and Hwang 2005; Chen 
and Nadziejko 2005; Lippmann et al. 2005b; 
Sun et al. 2005). Araujo et al. (2008) com-
pared the proatherogenic effects of ambient 
UFP with PM2.5 in apolipoprotein E–deficient 
mice. UFP-exposed mice exhibited significantly 
larger atherosclerotic lesions than mice exposed 
to PM2.5 or filtered air (Figure 3). 
Respiratory effects of PM exposure. PM 
Centers research has added to a wide body 
of literature investigating toxicologic mecha-
nisms and effects of PM in the respiratory 
system. Overall, the issue of respiratory effects 
and PM exposure has been reviewed recently 
with reference to work produced by the PM 
Centers as well as others (Boothe and Shendell 
2008; Salam et al. 2008). Salam focuses on 
asthma, whereas the Boothe and Shendell 
paper addresses some other end points in addi-
tion to respiratory effects. Results from clinical 
and panel studies in asthmatic and elderly sub-
jects, as well as experimental studies in animals 
and in vitro cellular systems with relevance 
to respiratory tissues were reported. The dis-
covery that UFP deposition is increased in 
asthmatic subjects during exercise has impor-
tant implications for defining populations at 
greater risk of PM-related effects (Chalupa 
et al. 2004; Daigle et al. 2003). Adjuvant 
effects of ambient PM in promoting aller-
gic airways responses occurred in a sensitized 
mouse model (Kleinman et al. 2005). Acute 
exposures to ambient PM in Seattle were asso-
ciated with increased inflammation in asth-
matic subjects, as measured by exhaled nitric 
oxide (Jansen et al. 2005; Koenig et al. 2005; 
Mar et al. 2005a). Respiratory effects in chil-
dren were also a focus. Increased risk of infant 
hospitalization for bronchiolitis was signifi-
cantly associated with subchronic and chronic 
exposures to PM in Los Angeles (Karr et al. 
2007), where exposures in the month prior 
to hospitalization (subchronic) and mean life-
time exposure (chronic) referenced to the case 
diagnosis date were assessed on the basis of 
data derived from the California Air Resources 
Board. Epidemiologic studies that linked 
the PM Centers and the Children’s Health 
Study (CHS) contributed findings that iden-
tify infants and children as important popula-
tions of concern for respiratory effects of PM 
(Gauderman et al. 2004, 2005, 2007; Molitor 
et al. 2007; Trenga et al. 2006). These studies 
demonstrate that exposure to PM2.5 and other 
air pollutants were associated with reduced 
lung function growth in children and provided 
evidence for compromised lung function. The 
CHS/PM Center studies identified traffic as 
a risk factor (Gauderman et al. 2004, 2005, 
2007; McConnell et al. 2006). 
Identification of new target tissues. UFP 
of carbon-13 were detected in the olfac-
tory bulbs of rats after inhalation exposure 
(Oberdörster et al. 2004), suggesting that the 
central nervous system is a potentially impor-
tant toxicologic target of PM2.5 (Figure 4). In 
support of this significant result, studies of 
mice chronically exposed to ambient PM2.5 
documented loss of brain neurons (Veronesi 
et al. 2005) and changes in gene expres-
sion in the brain consistent with inflamma-
tory effects (Gunnison and Chen 2005). In 
another study, proinflammatory cytokines 
were increased in brains of mice exposed to 
concentrated PM2.5 compared with those of 
control animals (Campbell et al. 2005). 
Chemical mechanisms of PM toxicity. To 
better identify the most toxic PM components 
and sources, the PM Centers have pursued 
experimental linkages between toxicologic 
properties and specific physical/chemical char-
acteristics of particles including size, surface 
area, and PM components such as transition 
metals, endotoxin, and organics including reac-
tive organic compounds. Multiple chemical 
and biological mechanisms by which PM can 
induce toxic effects in a variety of target cell 
types have been proposed (Frampton 2006; 
Yang et al. 2008). Oxidative stress, a common 
effect of toxicant exposure, is a change in the 
redox environment of the cell (Schafer and 
Buettner 2001) through changes in the ratios 
of concentrations of oxidized to reduced cel-
lular antioxidants. Oxidative stress occurs by 
increasing intracellular ROS or by depleting 
glutathione (GSH). GSH is the predominant 
antioxidant in cells and plays important roles 
in protecting against oxidative and electrophile 
stress (Rahman and MacNee 2000). A number 
of PM Center studies during the first 6 years 
contributed to what is now a strong eviden-
tiary basis for oxidative damage as a general 
toxicologic mechanism of PM injury (Delfino 
et al. 2005; Ghelfi et al. 2008; González-Flecha 
2004; Gurgueira et al. 2002; Li et al. 2003a, 
2003b; Rhoden et al. 2004, 2005; Tao et al. 
2003; Xia et al. 2006). There is widespread 
agreement throughout the PM Centers that 
oxidative stress may be a mechanism of major 
importance for cardiorespiratory effects. 
Studies of reactive chemical components 
of ambient PM samples reported that par-
ticles possess intrinsic chemical reactivity 
Figure 3. UFP is the most proatherogenic frac-
tion. Atherosclerotic lesions were quantitatively 
analyzed in serial aortic root sections and stained 
with oil red O. Lesional area was scored as square 
micrometers per section and averaged ≥ 25 sec-
tions per animal. Group averages are indicated by 
straight horizontal bars. One mouse exposed to 
filtered air (FA) was an obvious outlier in its group 
and was removed from the atherosclerotic lesion 
analysis. However, its inclusion did not modify the 
overall significance. Mice exposed to FA are repre-
sented by white circles (n = 14), fine particles (FP) 
by blue circles (n = 16), and UFPs by black circles 
(n = 15). Reproduced from Araujo et al. (2008) with 
permission from Wolters Kluwer.
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Figure 4. Time course of 13C tissue concentrations 
in lung, olfactory bulb, cerebrum, and cerebellum 
of rats after a 6-hr inhalation exposure to ultra-
fine (36 nm count median diameter) elemental 13C 
particles (n = 3 rats per time point). Adapted from 
Oberdörster et al. (2004) with permission from 
Taylor and Francis.
*p < 0.05 (ANOVA).
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that may play an important role in toxicity 
(Cho et al. 2005; Venkatachari et al. 2005). 
Covalent modification of biological molecules 
by reactive electrophilic compounds, particu-
larly organics, and ROS production are two 
key chemical mechanisms by which PM can 
disrupt intracellular biochemistry, ultimately 
altering gene expression and subcellular organ-
elle function in target cells. Center investi-
gators demonstrated covalent binding of a 
cellular enzyme by electrophilic agents, includ-
ing organic compounds, present in ambient 
PM (Rodriguez et al. 2005; Samet et al. 1999) 
and reported that PM can directly inhibit 
the activity of enzymes involved in oxidative 
stress response in a cell-free assay (Hatzis et al. 
2006). There is accumulating evidence that 
transition metals such as copper, vanadium, 
chromium, nickel, cobalt, and iron, as well as 
aromatic and polar organic substances, play a 
role in ROS production. An important role of 
metals may be alteration of signal transduction 
pathways involving oxidative stress (Samet 
et al. 2003). Assays that can screen for both 
oxidative and covalent binding properties of 
PM are of interest for comparing the toxico-
logic potential of PM from different sources, 
locations of interest, season, and other param-
eters of interest (Borm et al. 2007). 
Life shortening associated with exposure 
to PM. In analyses at the Harvard Center in 
which daily deaths in 10 European cities were 
investigated by examining all-cause, respira-
tory, and cardiovascular deaths for all ages and 
stratifying by age groups, it was found that the 
effect of air pollution is not limited to advanc-
ing mortality by a few weeks, but that effects 
persist for over a month after exposure. The 
short-term mortality effect size estimate for 
PM10 doubles when longer-term effects for 
all mortality and cardiovascular mortality are 
considered and becomes five times higher for 
respiratory mortality (Zanobetti et al. 2003). 
Reduction of ambient air pollution levels was 
associated with reduced total, cardiovascular, 
and lung cancer mortality in the Harvard Six 
Cities Cohort (Laden et al. 2006). Long-term 
exposure was associated with excess lung cancer 
in cohort studies of Pope et al. (2002), Laden 
et al. (2006), and Pope and Dockery (2006). 
Susceptibility factors and populations of 
concern for PM-induced health effects. When 
the PM Centers research was initiated, epide-
miologic studies had indicated that the elderly 
and people with cardiovascular or chronic 
lung disease were at greater risk for morbidity 
and mortality associated with acute PM expo-
sure. The PM Centers explored the basis for 
this susceptibility and also produced research 
findings that expand the spectrum of popu-
lations of concern. Support for the epide-
miologic observations that elderly and chronic 
obstructive pulmonary disease patients have 
higher rates of hospitalization and mortality 
associated with acute PM exposure has come 
from human clinical studies showing that 
elderly people experience greater effects of PM 
on HRV and blood parameters (Park et al. 
2005; Pope and Dockery 2006; Schwartz 
et al. 2005a, 2005b). Further support for the 
elderly as a population of concern comes from 
studies of geriatric laboratory animals (Elder 
et al. 2004a, 2004b). 
A study of PM-related daily mortal-
ity found greater effects in diabetic subjects 
(Zeka et al. 2006). The increase in mortality 
in diabetics may be related to increased sus-
ceptibility to the cardiovascular effects of PM 
exposure, as indicated by greater rate of hos-
pitalization for heart disease (Zanobetti and 
Schwartz 2002), sensitivity to changes in HRV 
(Park et al. 2005), and altered vasomotor func-
tion (O’Neill et al. 2005) in diabetic subjects. 
It is possible that these patients may be more 
susceptible to inflammatory effects of PM, 
which in turn affect vascular tissues (O’Neill 
et al. 2007). In contrast, recent results from 
the Women’s Health Initiative suggest that 
diabetics in this cohort were not at increased 
risk (Miller et al. 2007). More work on this 
subject is needed, and controlled human expo-
sures in diabetic studies have been initiated 
by the PM Centers (Frampton et al. 2006a). 
Schwartz et al. (2005b) reported an associa-
tion between presence or absence of the allele 
for glutathione-S-transferase M1 and the high 
frequency component of HRV. Genetic sus-
ceptibility is an area in which the PM Centers 
are currently increasing research focus. 
Advances in Critical 
Interdisciplinary Research Areas
Interdisciplinary research has been a hallmark 
of the PM Centers since their inception. Two 
subject areas that were exemplary in terms 
of bringing together multiple investigative 
perspectives were investigations of UFP and 
mobile sources. 
Ultrafine particles: unique in composition 
and toxicity. Center-based research allowed 
a major effort to characterize size distribu-
tions, chemical speciation, and the effect of 
atmospheric processes of UFP to be inte-
grated with toxicologic research (Donaldson 
and Stone 2003). UFP in urban airsheds are 
largely derived from fresh combustion sources, 
although secondary formation of UFP from 
atmospheric photochemical processes is also 
an important source (Sioutas et al. 2005). 
UFP freshly generated by combustion are 
short-lived and subsequently grow to form 
aggregates. UFP dominate particle number 
concentration in ambient PM samples while 
contributing little to PM mass concentrations. 
In part because of a complex fractal structure 
(Friedlander and Xiong 2000), UFP possess 
much greater surface area per unit mass than 
larger ambient particles. The large surface 
area, in turn, allows greater per-mass concen-
trations of adsorbed or condensed toxic air 
pollutants (oxidant gases, organic compounds, 
transition metals) to collect on UFP (Sioutas 
et al. 2005). Studies on ambient and model 
particles have concluded that the large specific 
surface area of UFP may be a key component 
in their toxicology (Oberdörster 2001). 
The PM Centers produced an integrated 
body of exposure and toxicologic studies on 
ambient and model UFP as well as studies of 
controlled human exposures. Dosimetry work 
showed that UFP will have significant accu-
mulation in the lung (Kreyling et al. 2006). 
In addition, UFP of varying composition can 
cross cellular membranes by diffusion (Geiser 
et al. 2005) and gain access to vulnerable tar-
gets within cells. The potential for translo-
cation from the site of lung deposition into 
systemic circulation, although rates have 
been low with test particles (Kreyling et al. 
2002), could have major mechanistic implica-
tions (Elder and Oberdörster 2006). Electron 
microscopy indicated subcellular penetration 
and mitochondrial damage by UFP in in vivo 
studies and, to a lesser extent, by fine particles 
(Li et al. 2003b). Disruption of mitochon-
drial functions may play an important role in 
PM-mediated health effects (Xia et al. 2007). 
In a study of size-segregated concentrated 
ambient PM samples, the ability of PM to 
catalyze ROS generation, an initial step in 
the induction of oxidative stress, was great-
est in the UFP fraction (Cho et al. 2005). Li 
et al. (2003a) summarized contrasting fea-
tures of coarse, fine, and ultrafine particles 
from Southern California, including relevant 
chemical and biological parameters. The toxi-
cologic findings correlated with PM OC and 
polycyclic aromatic hydrocarbon (PAH) com-
position, suggesting a role of organic agents in 
generating redox activity (Table 1). 
The PM Centers conducted controlled 
human exposure studies with UFP. Results 
from these studies were limited, because of small 
group sizes and because these exposures are neces-
sarily brief and conducted at low concentrations 
compared with the background PM exposures 
that may be experienced by urban study sub-
jects. In the first set of studies, short-term expo-
sures were conducted with 10–50 µg/m3 carbon 
UFP generated in the laboratory. Alterations in 
blood cell adhesion molecules and in a marker 
of vascular perfusion suggest that UFP expo-
sure may produce subtle changes in pulmonary 
vasoconstriction (Frampton 2007; Pietropaoli 
et al. 2004). A small but statistically signifi-
cant reduction in arterial oxygen saturation and 
some evidence for reduced HRV were found, 
although the small study size limited interpreta-
tion (Gong et al. 2008). An expanded focus on 
UFP in epidemiologic studies is needed but has 
been limited to date by the challenges of assess-
ing exposure to UFP. U.S. EPA PM Centers accomplishments (1999–2004)
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Traffic: mobile sources are highly relevant 
to the public health impacts of PM. The cen-
ter-based research context was particularly use-
ful in advancing the science on mobile sources 
of PM, the focus of an extensive international 
research effort. Numerous investigations of the 
physical and chemical attributes of PM col-
lected alongside freeways and in roadway tun-
nels were performed. The results have yielded 
data on size distribution, number and mass 
concentrations, chemical speciation, emis-
sions factors, volatility, penetration indoors, 
and the impact of atmospheric processes on 
roadway PM (Biswas et al. 2007; Fine et al. 
2004; Geller et al. 2006; Kuhn et al. 2005b, 
2005c; Phuleria et al. 2007; Sardar et al. 2005; 
Zhu et al. 2005). Detailed spatial profiles of 
UFP concentration at varying distances from 
freeways were generated (Zhu et al. 2002a, 
2002b). Concentrations of UFP drop exponen-
tially with distance from the center of the free-
way, reaching upwind levels at approximately 
300 meters. The size distribution of UFP also 
changed markedly with distance reflective of 
coagulation and other atmospheric particle pro-
cesses. Winter particle number concentrations 
are greater than summer, indicating formation 
of UFP from vapor condensation. Exposure to 
motor vehicle exhaust emissions during com-
muting may constitute a substantial fraction of 
daily personal PM exposure, especially to UFP 
(Sioutas et al. 2005; Zhu et al. 2007).
Toxicologic studies of traffic-derived aero-
sols studied by PM Centers included in vitro 
findings that implicate PM collected in free-
way microenvironments in the production 
of reactive chemical species, stimulation of 
proinflammatory effects, and altered gene 
expression in cellular test systems. UFP frac-
tion, carbonaceous content, and an organic 
tracer for vehicles were linked with toxico-
logic activity of PM in a variety of assays 
(Cho et al. 2005; Li et al. 2003a, 2003b). 
Several studies of laboratory animals exposed 
to PM on or near busy roadways have identi-
fied cardiovascular and allergic airways effects 
(Elder et al. 2004b, 2007; Kleinman et al. 
2005). Evidence that traffic-derived air pollu-
tion affects humans has expanded significantly 
during the first 6 years of PM Centers fund-
ing, implicating mobile source in respiratory 
effects in children (Gauderman et al. 2004, 
2005, 2007; McConnell et al. 2006), cardio-
vascular effects (Riediker et al. 2004) includ-
ing myocardial infarction (Peters et al. 2004; 
Tonne et al. 2007), and low birth weight 
(Wilhelm and Ritz 2003). Toxicologic stud-
ies are needed to follow up the epidemiologic 
findings of effects on the fetus. In a reanalysis 
of data from the Harvard Six Cities study 
of daily mortality and PM, source appor-
tionment approaches identified the mobile 
source factor as most strongly associated with 
increased daily mortality (Laden et al. 2000). 
Policy Implications of PM 
Centers Research 
Research findings from the PM Centers have 
had a significant influence on science pol-
icy, most directly in terms of the science that 
underlies the National Ambient Air Quality 
Standards (NAAQS) for PM. The findings of 
morbidity and mortality that form the scien-
tific basis for the short-term and annual PM 
NAAQS were strengthened through epide-
miologic and statistical research. Mechanistic 
investigations and studies of preclinical 
markers established biological plausibility for 
observed relationships between ambient air 
PM and observed acute mortality. In per-
sonal exposure studies, validation of the use of 
central site ambient concentrations provided 
crucial support to the interpretation of epide-
miologic results. 
The PM NAAQS are based on mass con-
centration. The state of the science suggests 
that no single parameter, whether mass, size 
fraction, surface area, or a particular chemical 
component, is responsible for all the diverse 
mechanisms and toxicologic end points that 
have been associated with PM, and a more 
sophisticated approach to standards will be 
needed. Based on findings from the PM 
Centers and others, the potential efficacy 
of number and component based standards 
should be assessed. As more data become 
available to link specific PM emissions 
sources, chemical composition, and physical 
characteristics with quantitative measures of 
toxicity, the question of source-specific con-
trol strategies to maximize public health pro-
tection also needs to be considered. 
The increasing level of evidence that UFP 
are toxic but may not be controlled well by 
existing regulatory approaches raises other pol-
icy issues including mitigation of the risk of 
health effects associated with housing, schools, 
parks, and other heavily populated public facil-
ities located near heavily traveled roadways, 
busy seaports, and other combustion sources 
that are the major urban sources of exposure 
to UFP. There are potential environmental 
justice concerns associated with transporta-
tion-derived combustion, as it is often areas 
of lower socioeconomic status that are most 
affected by proximity to these sources. 
Looking Forward: Research 
Priorities and Current Directions
As the PM Centers program moved forward 
into the second phase, the original guiding 
research priorities were reevaluated, and new 
priorities have emerged. Several areas of inves-
tigation identified during the development 
of the 1997 PM NAAQS are still of critical 
relevance today, but the scientific questions 
being asked have been refined. Some research 
topics being pursued in the current round of 
PM Centers are described below.
Particle source characterization and PM 
components as factors in PM toxicity. The 
PM Centers current research agenda includes 
detailed studies of the physical and chemi-
cal attributes of ambient PM associated with 
specific sources. The current science indi-
cates that multiple mechanisms of injury, in 
backgrounds modified by host susceptibility 
factors, can be activated by a variety of PM 
components and characteristics. To address 
the complexity associated with assessing the 
health effects associated with specific PM 
components, the current PM Centers research 
agenda compares toxicologic properties of 
PM by source type in addition to compo-
sitional attributes. Mobile sources continue 
to be a priority focus, and there is a need to 
better understand the fate of fossil fuel com-
bustion emissions from a variety of mobile 
and stationary sources, including airports, sea-
ports, and other sources as well as roadways. 
Building upon the productive body of work 
on mobile source PM in the first 6 years of 
PM Center work, the current PM Centers 
include human panel and clinical studies and 
toxicologic studies in laboratory animals and 
in vitro systems that test hypotheses about the 
effects of mobile source PM exposures. Source 
apportionment efforts are ongoing as well, to 
build on previous work that found mobile 
sources are dominant contributors to urban 
UFP loads. In vitro studies will pay particular 
attention to UFP, organic compounds, and 
transition metals. UFP formed from nuclea-
tion of ambient air vapors are a new focus, as 
they may be especially toxic. 
Dosimetry and toxicokinetics. Research at 
the PM Centers is addressing particle deposi-
tion, uptake, distribution, and fate, including 
Table 1. Contrasting features of coarse, fine, and ultrafine particles.
Parameters  Coarse PM10  Fine PM10  Ultrafine PM10
Size (µm)  2.5–10  2.5–0.15  < 0.15
OC content  +  ++  +++ 
EC content  +  ++  +++
Metals (% of total elements)  +++  ++  +
PAH content  +  +  +++
Redox activity (DTT assay)  +  ++  +++
HO-1 induction  +  ++  +++
GSH depletion  +  +++  +++
Mitochondrial damage  None  Some  Extensive
Data from Li et al. (2003a).Fanning et al.
172  v o l u m e  117 | n u m b e r 2 | February 2009  •  Environmental Health Perspectives
the effects of developmental stage on disposi-
tion of PM. Cell culture systems with gene 
expression and proteomics methods are being 
used for studies of metabolic and genetic 
responses that will be useful for toxicokinetics. 
Studies of the dosimetry and toxicokinetics 
associated with UFP are especially important, 
given previous PM Centers findings that these 
particles distribute into systemic circulation 
and secondary target organs such as the CNS, 
and can enter cells and subcellular organelles.
Mechanisms. All the current PM Centers 
have a strong focus on continuing to develop 
understanding of the toxic mechanisms 
that underlie clinically and epidemiologi-
cally defined adverse health effects of PM. 
Mechanisms being pursued include reactive 
chemical species that cause cellular oxidative 
stress responses. In the first 6 years, studies 
of oxidative damage associated with PM were 
performed using diverse chemical species, cell 
culture experiments, and laboratory animal 
studies. Evolving from that work, the current 
PM Centers studies are looking at markers 
of oxidative stress processes in humans and a 
range of clinical and preclinical biomarkers. 
The list of gene products that can be used 
as indicators of PM exposure or toxicity in 
various cell types has expanded. Mechanistic 
hypotheses are being tested in panel and other 
epidemiologic studies.
Susceptibility. Susceptibility is a major 
theme, drawing on the work from the earlier 
center and noncenter investigators showing 
that individuals with pulmonary and cardiac 
health conditions, elderly, children, diabet-
ics, and others may be more susceptible to the 
adverse effects of PM exposure than the general 
population. The PM Centers are looking at 
early life exposures to PM in animal models, 
performing panel studies of elderly subjects or 
subjects with compromised health status, using 
a large established cohort to identify how risk 
factors for PM-related health outcomes may be 
modified by individual factors such as medica-
tion use, diet, and genotype. Compromised 
animal models are a key theme of current 
research into susceptibility. PM exposure stud-
ies on ApoE–/– mice (an atherosclerosis-prone 
model), hypertensive rats, and diabetic rats are 
all planned or underway. 
Conclusions 
In 1998, a committee of the NRC pub-
lished the first of a four-volume report titled 
“Research Priorities for Airborne Particulate 
Matter” that identified the 10 highest-priority 
targets for PM research (NRC 1998). Within 
the research portfolio of the PM Centers, the 
priority areas have been addressed. A subse-
quent NRC report (2001) emphasized that 
these research priorities require multidisci-
plinary approaches. Recognizing that progress 
in understanding the health effects consequent 
to air pollution exposure requires talents from 
highly divergent fields, we believe that the PM 
Centers effectively promote interdisciplinary 
cross-fertilization. The next 5 years of this 
program will bring the experience and results 
of the first centers to fruition in new, focused 
studies that we hope will be instrumental in 
addressing the difficult scientific and public 
health policy problems that arise from ubiqui-
tous particulate air pollution. 
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